Roluperidone's pivotal phase III trial is on track, with results expected next year and strong investor support

News on schizophrenia and mental health matters
1

This is the medication for negative symptoms. Is in phase 3.

4 Likes
2

Thank you nirvanana ..

1 Like
3

Previously it failed ..

1 Like
4

3 To four years

1 Like
5

Nice to know there are options in the pipeline. Just hoping it is not a dud and it makes a difference on negative symptoms. :pill: :hand_with_index_finger_and_thumb_crossed:

2 Likes